Medicare Enrolled

Dr. Bishnu Sapkota, M.D

Neurology · Granbury, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
1315 WATERS EDGE DR STE 107, Granbury, TX 76048
8179643013
Registered in NPPES since 2009
NPI: 1679702872 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sapkota from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sapkota? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sapkota

Dr. Bishnu Sapkota is a neurology specialist in Granbury, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Sapkota performed 14,741 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Sapkota received a total of $31,271 from 79 pharmaceutical and/or device companies across 1906 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sapkota is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years of NPI registration ▲ Top 6% volume in TX $31,271 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
14,741
Medicare services
Top 6% in TX for neurology
Not available
Unique patients (not deduplicated)
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
12,945 $5 $23
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
625 $86 $283
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
360 $56 $192
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
210 $117 $433
Limited needle EMG of arm or leg muscles
A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area.
114 $45 $196
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
109 $147 $590
Punch biopsy of additional skin growth
A small circular tool is used to remove a sample of an extra skin growth for laboratory examination.
65 $45 $163
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
63 $90 $395
EEG brain wave test, 61-119 minutes
This procedure measures electrical activity in the brain using electrodes placed on the scalp. It records brain wave patterns for a duration between 61 and 119 minutes.
59 $60 $268
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
57 $72 $240
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 35 $59 $187
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
34 $86 $379
Punch biopsy of first skin growth
A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination.
33 $92 $331
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
20 $63 $283
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
12 $43 $155
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$31,271
Total received (2018-2024)
Avg $4,467/year across 7 years
Top 13% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
79
Companies
1,906
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,255
2023
$8,626
2022
$4,005
2021
$3,835
2020
$3,191
2019
$2,823
2018
$2,536

Payments by company (2024)

ABBVIE INC.
$991
Medtronic, Inc.
$938
UCB, Inc.
$573
Novartis Pharmaceuticals Corporation
$357
PFIZER INC.
$354
Lilly USA, LLC
$343
Neurelis, Inc.
$274
Biogen, Inc.
$262
ARGENX US, INC.
$260
Sumitomo Pharma America, Inc.
$248
Lundbeck LLC
$187
Genentech USA, Inc.
$170
ACADIA Pharmaceuticals Inc
$148
MDD US Operations, LLC
$141
LivaNova USA, Inc.
$132
REVANCE THERAPEUTICS, INC.
$104
Otsuka America Pharmaceutical, Inc.
$88
Eisai Inc.
$84
Alexion Pharmaceuticals, Inc.
$81
Amneal Pharmaceuticals LLC
$67
Aucta Pharmaceuticals, Inc.
$66
Amgen Inc.
$56
Grifols USA, LLC
$55
JAZZ PHARMACEUTICALS INC.
$51
Alnylam Pharmaceuticals Inc.
$38
E.R. Squibb & Sons, L.L.C.
$33
Neurocrine Biosciences, Inc.
$27
CSL Behring
$20
MITSUBISHI TANABE PHARMA AMERICA, INC.
$19
Vanda Pharmaceuticals Inc.
$16
TG Therapeutics, Inc.
$15
Teva Pharmaceuticals USA, Inc.
$15
Tonix Medicines, Inc.
$14
Amylyx Pharmaceuticals, Inc.
$14
ANI Pharmaceuticals, Inc.
$14
Top 3 companies account for 40.0% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$2,993
UCB, Inc.
$2,768
ABBVIE INC.
$1,655
Novartis Pharmaceuticals Corporation
$1,550
Biogen, Inc.
$1,480
Teva Pharmaceuticals USA, Inc.
$1,398
AbbVie Inc.
$1,159
Celgene Corporation
$1,046
Amgen Inc.
$1,007
Medtronic, Inc.
$984
PFIZER INC.
$881
GENZYME CORPORATION
$804
Neurelis, Inc.
$757
ACADIA Pharmaceuticals Inc
$744
Lilly USA, LLC
$714
Lundbeck LLC
$638
Genentech USA, Inc.
$625
Amneal Pharmaceuticals LLC
$572
Supernus Pharmaceuticals, Inc.
$522
UPSHER-SMITH LABORATORIES LLC
$499
Biohaven Pharmaceuticals, Inc.
$483
Allergan, Inc.
$444
Grifols USA, LLC
$435
LivaNova USA, Inc.
$420
SK Life Science, Inc.
$393
ARGENX US, INC.
$370
Upsher-Smith Laboratories LLC
$368
Adamas Pharmaceuticals, Inc.
$344
Biohaven Pharmaceutical Holding Company Ltd.
$313
IMPEL PHARMACEUTICALS INC.
$293
Avanir Pharmaceuticals, Inc.
$291
Eisai Inc.
$291
Allergan Inc.
$269
Otsuka America Pharmaceutical, Inc.
$253
Sumitomo Pharma America, Inc.
$248
Alexion Pharmaceuticals, Inc.
$234
CSL Behring
$211
Greenwich Biosciences, Inc.
$173
MDD US Operations, LLC
$162
Kyowa Kirin, Inc.
$160
ARBOR PHARMACEUTICALS, INC.
$156
Currax Pharmaceuticals LLC
$148
Neurocrine Biosciences, Inc.
$132
Ipsen Biopharmaceuticals, Inc
$114
REVANCE THERAPEUTICS, INC.
$104
Alnylam Pharmaceuticals Inc.
$102
Avion Pharmaceuticals
$100
Horizon Therapeutics plc
$99
EMD Serono, Inc.
$89
AQUESTIVE THERAPEUTICS, INC.
$86
JAZZ PHARMACEUTICALS INC.
$85
Promius Pharma LLC
$84
Impax Laboratories, Inc.
$78
Amylyx Pharmaceuticals, Inc.
$77
Nevro Corp.
$75
Aucta Pharmaceuticals, Inc.
$66
EISAI INC.
$60
Almatica Pharma LLC
$59
MITSUBISHI TANABE PHARMA AMERICA, INC.
$57
US WorldMeds, LLC
$56
Saol Therapeutics Inc.
$55
Azurity Pharmaceuticals, Inc.
$40
Assertio Therapeutics, Inc.
$39
Arbor Pharmaceuticals, Inc.
$37
ANI Pharmaceuticals, Inc.
$32
Abbott Laboratories
$31
Zogenix Inc.
$30
Mallinckrodt Enterprises LLC
$28
Averitas Pharma Inc.
$26
Acorda Therapeutics, Inc
$25
Merz Pharmaceuticals, LLC
$22
Baxter Healthcare
$20
Boston Scientific Corporation
$18
Vanda Pharmaceuticals Inc.
$16
CATALYST PHARMACEUTICALS, INC.
$15
TG Therapeutics, Inc.
$15
Tonix Medicines, Inc.
$14
BOSTON SCIENTIFIC CORPORATION
$14
Ultragenyx Pharmaceutical Inc.
$13
Top 3 companies account for 23.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · COMIRNATY · CONTRAVE · COPAXONE · CREXONT · Cambia · DAXXIFY · DUOPA · DYSPORT · Dhivy · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FIRDAPSE · Fintepla · Fycompa · GENERAL DBS · GENERAL PAIN MANAGEMENT · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gocovri · Gralise · Hillrom - Volara System · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INTELLIS ADAPTIVESTIM · KESIMPTA · KISUNLA · LEMTRADA · LEQEMBI · LIORESAL (BACLOFEN) · LYRICA · LYVISPAH · Leqembi · MAYZENT · MYOBLOC · Mavenclad · Motpoly XR · NAMZARIC · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · ONZETRA XSAIL · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Omnia · Ongentys · PANZYGA · PERCEPT PC BRAINSENSE · PLEGRIDY · PONVORY · PURIFIED CORTROPHIN GEL · Privigen · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · RADICAVA · RELYVRIO · REXULTI · RYTARY · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · SYMPAZAN · Senza · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Granbury?
Compare neurologists in the Granbury area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
1
County median income
$86,802
Nearest hospital to ZIP centroid (approximate)
LAKE GRANBURY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sapkota is a mixed practice specialist, with above-average Medicare volume (top 6% in TX), with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sapkota experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Sapkota performed 12,945 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sapkota receive payments from pharmaceutical companies?
Yes. Dr. Sapkota received a total of $31,271 from 79 companies across 1,906 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sapkota's costs compare to other neurologists in Granbury?
Dr. Sapkota's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sapkota) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →